To test the need of senescence-inducing p21Cip1 for cancer immune control and to determine whether senescence induction is also needed for tumours other than RT2-cancers, we studied the role of p21Cip1 in the immune control of lymphomas. Here, CDKN1A is linked to neoplasm.